comparemela.com

Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) CEO Norbert W. Bischofberger acquired 1,378,901 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were acquired at an average cost of $0.88 per share, with a total value of $1,213,432.88. Following the transaction, the chief executive officer now directly […]

Related Keywords

United States ,Kronos Bio ,Norbertw Bischofberger ,Acuta Capital Partners ,Nasdaq ,Marquette Asset Management ,Cerity Partners ,Kronos Bio Company Profile ,Virtu Financial ,Acadian Asset Management ,Securities Exchange Commission ,Kronos Bio Inc ,Get Free Report ,Exchange Commission ,Asset Management ,Capital Partners ,Kronos Bio Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.